Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Interim Statements of Loss and Comprehensive Loss (Unaudited)

v3.10.0.1
Consolidated Condensed Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Expenses    
Research and development $ 1,019,120 $ 1,934,643
General and administrative 986,470 744,621
Operating expenses 2,005,590 2,679,264
Other loss (income)    
Change in fair value of derivative liability 220 (56,568)
Foreign exchange loss 5,838 43,866
Interest income (19,844) (156)
Other loss (income) (13,786) (12,858)
Net and comprehensive loss for the period 1,991,804 2,666,406
Computation of basic loss per share    
Net and comprehensive loss for the period 1,991,804 2,666,406
Series B Preferred stock dividend 36,085 41,666
Computation of basic loss per share $ 2,027,889 $ 2,708,072
Basic and fully diluted loss per share $ 0.09 $ 0.18
Basic weighted average number of shares 22,969,090 15,292,781